Translational Oncology Research Program

Research output

Research output per year 1977 2017 2021 2022 2023 2024 2025

• 121066 Citations
• 150 h-index
• 2207 Article
• 255 Review article
• 88 Chapter
• 78 Conference contribution
• 253 More
  • 77 Comment/debate
  • 48 Editorial
  • 38 Letter
  • 27 Conference article
  • 23 Paper
  • 17 Short survey
  • 9 Foreword/postscript
  • 7 Book
  • 3 Meeting Abstract
  • 1 Abstract
  • 1 Other contribution
  • 1 Patent
  • 1 Preprint

Research output per year

Research output per year

Search results

• 2021

  Every three weekly irinotecan for refractory/relapsed small cell lung cancer.

  Nutalapati, S., Yan, D., Morgan, R. & Chauhan, A., May 20 2021.

  Research output: Contribution to conference › Abstract

  • Small Cell Lung Cancer 100%
  • Irinotecan 100%
  • Patient 62%
  • Adverse Event 50%
  • Neuroendocrine Carcinoma 37%